Key result
NPR3 rs2270915 G/G genotype is linked to ~94% higher odds of diastolic dysfunction.
Why the study?
Whether the NPR3 rs2270915 SNP (N521D) is associated with alterations in natriuretic peptide levels and cardiac structure and function was unknown.
Is the NPR3 rs2270915 SNP associated with diastolic dysfunction and altered natriuretic peptide levels in the general community?
Population
1931 randomly selected residents of Olmsted County, Minnesota
Comparison
Homozygotes G/G vs wild type A/A plus heterozygotes A/G for NPR3 rs2270915 SNP
Design
Cross-sectional genetic association study with echocardiography
Authors
Loading...
NPR3 rs2270915 variant shows hypothesis-generating links to NPs and myocardial parameters; larger studies needed before clinical relevance.
Cross-Sectional (n=1,931)
No
Is the NPR3 rs2270915 SNP associated with diastolic dysfunction and altered natriuretic peptide levels in the general community?
Odds Ratio: 1.94 (95% CI 1.07–3.51)
Absolute Event Rate: 43% vs 28%
p-value: p=0.03
A functional genetic variant in NPR3 (rs2270915) is independently associated with diastolic dysfunction without affecting circulating natriuretic peptide levels.
Pereira et al. (2014) conducted a cross-sectional in Diastolic dysfunction (n=1,931). NPR3 rs2270915 G/G genotype vs. NPR3 rs2270915 A/A or A/G genotypes was evaluated on Diastolic dysfunction (OR 1.94, 95% CI 1.07-3.51, p=0.03). The NPR3 rs2270915 G/G homozygous genotype was independently associated with a higher prevalence of diastolic dysfunction compared to A/A and A/G genotypes (OR 1.94).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: